|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00404950 |
|
Date of registration:
|
28/11/2006 |
|
Primary sponsor: |
|
|
Public title:
|
Effects of Hyperglycemia During Cardiopulmonary Bypass on Renal Function
|
|
Scientific title:
|
Effects of Hyperglycemia During Cardiopulmonary Bypass on Renal Function |
|
Date of first enrolment:
|
July 2005 |
|
Target sample size:
|
200 |
|
Recruitment status: |
Active, not recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00404950 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case-Only, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Paul Heerdt, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Associate Professor |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Male and female patients = 50 years of age
2. Patients undergoing on pump cardiopulmonary bypass for either myocardial
revascularization (coronary artery bypass graft) or valvular surgery (valve repair or
replacement)
Exclusion Criteria:
1. Patients with insulin dependent diabetes
2. Patients with preexisting renal dysfunction defined as Creatinine> 2 mg/dl
3. Patients in need of emergency cardiac procedures
Age minimum:
50 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Diabetes
|
|
Hyperglycemia
|
|
Secondary ID(s)
|
|
0408007400
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|